Kura Oncology, Inc. (KURA)
NASDAQ: KURA · Real-Time Price · USD
6.02
-0.04 (-0.58%)
At close: Aug 1, 2025, 4:00 PM
6.10
+0.08 (1.41%)
After-hours: Aug 1, 2025, 5:22 PM EDT
Revance Therapeutics Market Cap
Kura Oncology has a market cap or net worth of $521.18 million as of August 1, 2025. Its market cap has decreased by -70.55% in one year.
Market Cap
521.18M
Enterprise Value
-117.66M
1-Year Change
-70.55%
Ranking
Category
Stock Price
$6.02
Market Cap Chart
Since November 5, 2015, Kura Oncology's market cap has increased from $113.70M to $521.18M, an increase of 358.38%. That is a compound annual growth rate of 16.92%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 31, 2025 | 523.80M | -22.66% |
| Dec 31, 2024 | 677.30M | -36.58% |
| Dec 29, 2023 | 1.07B | 28.64% |
| Dec 30, 2022 | 830.20M | -10.90% |
| Dec 31, 2021 | 931.80M | -49.69% |
| Dec 31, 2020 | 1.85B | 197.24% |
| Dec 31, 2019 | 623.10M | 16.69% |
| Dec 31, 2018 | 534.00M | 15.51% |
| Dec 29, 2017 | 462.30M | 266.61% |
| Dec 30, 2016 | 126.10M | -29.75% |
| Dec 31, 2015 | 179.50M | 57.87% |
| Nov 5, 2015 | 113.70M | - |
View and export this data all the way back to 2015. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 678.89B |
| Johnson & Johnson | 400.22B |
| AbbVie | 341.90B |
| AstraZeneca | 236.88B |
| UnitedHealth Group | 233.14B |
| Novartis AG | 227.02B |
| Abbott Laboratories | 223.31B |
| Novo Nordisk | 221.96B |